CCL17 and Alzheimer disease: From an immunological point of view, characteristics of AD have been shown to be related to the abnormal overexpression and modulation of the thymus and the secretion of activation-regulated chemokines (TARC/CCL17) and macrophage-derived chemokines (MDC/CCL22) in human keratinocytes [15].